|
Vaginally Administrated Testosterone |
We are developing a vaginally administered testosterone treatment to shrink uterine fibroids, which are a leading cause of gynecological procedures. This drug candidate may also have utility in treating Female Sexual Dysfunction (FSD).
[Return to Research and Development Pipeline] |
|